This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Browse
Bacillus coagulans
Shelf-stable spore-form probiotic.
Aliases (6)
B. coagulans · GanedenBC30 · GBI-30 · 6086 · sporebiotic · spore probiotic
TYPICAL DOSE
—
ROUTE
—
CYCLE
—
STORAGE
—
Overview
What is Bacillus coagulans?
Shelf-stable spore-form probiotic. GanedenBC30 strain shows IBS + post-exercise recovery + URTI prevention RCT signals. OPTIONAL-ADD for training-cycle support.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
Was this helpful?
Your feedback shapes what we research deeper.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
Loading…
✎
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.
Discussion — click to load ▸
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources
Related compounds
Cross-referenced from Bacillus coagulansLactobacillus rhamnosus GG
OPTIONAL-ADD
Lactic acid bacterium probiotic strain isolated 1985 by Gorbach + Goldin. One of the most-studied probiotic strains in clinical literature. Adheres to intestinal epithelium → transient colonization (~7-14 days).
MEDIUM
Bifidobacterium
OPTIONAL-ADD
Genus of Gram-positive anaerobic gut bacteria. Dominant in breast-fed infant microbiota; declines with age (the "bifido decline" is one of the most consistent age-related microbiome shifts). Common commercial probiotic strains: B. longum 35624 (Align), B. lactis BB-12, B. infantis EVC001.
MEDIUM
Akkermansia muciniphila
OPTIONAL-ADD
Gram-negative mucin-degrading commensal gut bacterium. Comprises 1-4% of healthy adult gut microbiota; depleted in obesity, T2D, IBD, NAFLD. First "next-generation probiotic" approved for commercial sale in EU (2022) + US (Pendulum 2020).
MEDIUM